Your browser doesn't support javascript.
loading
Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa.
Hunjan, Manrup Kaur; Bardhan, Ajoy; Harper, Natasha; Langman, Gerald; Ajayi, Bamidele; Suresh, Vijay; Heagerty, Adrian H M.
Afiliação
  • Hunjan MK; Adult Epidermolysis Bullosa Service, Solihull Hospital, University Hospitals Birmingham NHS Trust, Birmingham, UK.
  • Bardhan A; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Harper N; Adult Epidermolysis Bullosa Service, Solihull Hospital, University Hospitals Birmingham NHS Trust, Birmingham, UK.
  • Langman G; Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.
  • Ajayi B; Adult Epidermolysis Bullosa Service, Solihull Hospital, University Hospitals Birmingham NHS Trust, Birmingham, UK.
  • Suresh V; Department of Cellular Pathology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Trust, Birmingham, UK.
  • Heagerty AHM; Department of Renal Medicine, Heartlands and Solihull Hospitals, University Hospitals Birmingham NHS Trust, Birmingham, UK.
Clin Exp Dermatol ; 47(8): 1588-1590, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35426452
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epidermólise Bolhosa Distrófica / Epidermólise Bolhosa / Glomerulonefrite por IGA / Antineoplásicos Limite: Humans Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epidermólise Bolhosa Distrófica / Epidermólise Bolhosa / Glomerulonefrite por IGA / Antineoplásicos Limite: Humans Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido